Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Buy of Gen-Probe Clears German Regulatory Review

NEW YORK (GenomeWeb News) – German regulators have cleared Hologic's $3.7 billion purchase of Gen-Probe, the two companies said today.

The deal, under which Hologic will pay $82.75 for each share of Gen-Probe stock, cleared US antitrust review last month and with clearance from Germany's Federal Cartel Office, required antitrust clearances have been received, the companies said.

The purchase is expected to be completed on or about Aug. 1. Gen-Probe is holding a special shareholders meeting on July 1 at its San Diego headquarter to vote on the deal.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.